Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken S Rosenthal

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|December 3, 2004
Immune peptide enhancement of peptide based vaccinesKen S Rosenthal
Journal of Medical Education and Curricular Development|January 20, 2018
Interactive Journal Club: Teaching an Old Dog New TricksJudith Rosenthal, Ken S Rosenthal
Journal of Virology|March 1, 2003
Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potentialHanwen Mao, Ken S Rosenthal
Clinical and Vaccine Immunology : CVI|August 9, 2006
Vaccines: all things consideredKen S Rosenthal, Daniel H Zimmerman
Frontiers in Bioscience : a Journal and Virtual Library|December 1, 2004
The L.E.A.P.S. approach to vaccine developmentDaniel H Zimmerman, Ken S Rosenthal
Microbial Biotechnology|September 8, 2011
J-LEAPS peptide and LEAPS dendritic cell vaccinesKen S Rosenthal, Patricia Taylor, Daniel H Zimmerman
Journal of Clinical & Cellular Immunology|July 23, 2019
Why Don't We Have a Vaccine Against Autoimmune Diseases? - A ReviewKen S Rosenthal, Roy Carambula, Daniel H Zimmerman
Journal of Immunology Research|May 2, 2017
LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse ModelKen S Rosenthal, Sarah Stone, Gary Koski, et al.
The Journal of Dermatological Treatment|March 9, 2013
Concurrent treatment of chronic psoriasis and asthma with ustekinumabAjay Amarnani, Ken S Rosenthal, Jorge M Mercado, et al.
International Immunopharmacology|July 8, 2019
Lessons from next generation influenza vaccines for inflammatory disease therapiesDaniel H Zimmerman, Roy E Carambula, Jason Ciemielewski, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience : a Journal and Virtual Library|December 3, 2004
Immune peptide enhancement of peptide based vaccinesKen S Rosenthal
Journal of Medical Education and Curricular Development|January 20, 2018
Interactive Journal Club: Teaching an Old Dog New TricksJudith Rosenthal, Ken S Rosenthal
Journal of Virology|March 1, 2003
Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potentialHanwen Mao, Ken S Rosenthal
Clinical and Vaccine Immunology : CVI|August 9, 2006
Vaccines: all things consideredKen S Rosenthal, Daniel H Zimmerman
Frontiers in Bioscience : a Journal and Virtual Library|December 1, 2004
The L.E.A.P.S. approach to vaccine developmentDaniel H Zimmerman, Ken S Rosenthal
Microbial Biotechnology|September 8, 2011
J-LEAPS peptide and LEAPS dendritic cell vaccinesKen S Rosenthal, Patricia Taylor, Daniel H Zimmerman
Journal of Clinical & Cellular Immunology|July 23, 2019
Why Don't We Have a Vaccine Against Autoimmune Diseases? - A ReviewKen S Rosenthal, Roy Carambula, Daniel H Zimmerman
Journal of Immunology Research|May 2, 2017
LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse ModelKen S Rosenthal, Sarah Stone, Gary Koski, et al.
The Journal of Dermatological Treatment|March 9, 2013
Concurrent treatment of chronic psoriasis and asthma with ustekinumabAjay Amarnani, Ken S Rosenthal, Jorge M Mercado, et al.
International Immunopharmacology|July 8, 2019
Lessons from next generation influenza vaccines for inflammatory disease therapiesDaniel H Zimmerman, Roy E Carambula, Jason Ciemielewski, et al.
Pageof 2